These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 8355197)
1. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats. Soltis EE; Jewell AL; Dwoskin LP; Cassis LA Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311 [TBL] [Abstract][Full Text] [Related]
3. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat. Cody RJ; Binkley PF; Haas GJ; Brown DM Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227 [TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II? O'Sullivan JB; Black MJ; Bertram JF; Bobik A J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732 [TBL] [Abstract][Full Text] [Related]
7. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model]. Ponchon P; Elghozi JL Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure effects of the angiotensin II receptor blocker, losartan. Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. Cassis LA; Rippetoe PE; Soltis EE; Painter DJ; Fitz R; Gillespie MN J Pharmacol Exp Ther; 1992 Sep; 262(3):1168-72. PubMed ID: 1527721 [TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. Devlin AM; Davidson AO; Gordon JF; Campbell AM; Morton JJ; Reid JL; Dominiczak AF J Hum Hypertens; 1995 Jun; 9(6):497-500. PubMed ID: 7473534 [TBL] [Abstract][Full Text] [Related]
11. Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat. Oparil S; Yang RH; Jin HG; Chen SJ; Meng QC; Berecek KH; Wyss JM Am J Med Sci; 1994 Feb; 307 Suppl 1():S26-37. PubMed ID: 8141161 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats. Lark LA; Wappel SM; Weyhenmeyer JA J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738 [TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [TBL] [Abstract][Full Text] [Related]
14. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone. Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
16. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats. Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925 [TBL] [Abstract][Full Text] [Related]
17. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis]. Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. Morton JJ; Beattie EC; MacPherson F J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats. Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]